Ledger.Open graph →
SEC Form D · filed November 6, 2020

MIRAGEN THERAPEUTICS, INC

Offering
$91.0M
Sold
$91.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOULDER, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Lee M. Rauch · Boulder, COExec · DirectorJonathan Violin · Philadelphia, PAExecPeter E. Harwin · Boulder, CODirectorDiana A. Escolar · Boulder, COExecJoesph L. Turner · Boulder, CODirectorJonathan Violin · Philadelphia, PAExecJames, Iii B. Mcginty · Terrell, TXDirectorArlene M. Morris · Boulder, CODirectorLee M. Rauch · Boulder, COExec · DirectorJoesph L. Turner · Boulder, CODirectorDiana A. Escolar · Boulder, COExecAnthony B. Lennen · Indianapolis, INExecAmy D. Glover · Indianapolis, INExecTomas E. Kiselak · Boulder, CODirectorTomas N. Diaz Mathe · Irving, TXDirectorPeter E. Harwin · Boulder, CODirectorNull Assure Fund Management Ii · Salt Lake City, UTDirectorJason A. Leverone · Boulder, COExecJeffrey S. Hatfield · Boulder, CODirectorTomas E. Kiselak · Boulder, CODirectorMark Carhart · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗